ephrin-B1 Activators
Ephrin-B1 activators constitute a diverse set of chemicals that intricately modulate the activity of ephrin-B1, a transmembrane ligand crucial for diverse cellular processes such as axon guidance, neuronal development, and tissue patterning. While direct activators of ephrin-B1 are limited, various compounds indirectly influence its expression and function through intricate regulatory pathways. Anacardic Acid, for instance, directly activates ephrin-B1 by inhibiting the acetyltransferase activity of p300. This inhibition prevents the acetylation of ephrin-B1, enhancing its interaction with Eph receptors and promoting downstream signaling events crucial for cell repulsion and adhesion. Similarly, compounds like DAPT indirectly activate ephrin-B1 by inhibiting the Notch signaling pathway. DAPT, as a γ-secretase inhibitor, relieves Notch-mediated repression, leading to increased ephrin-B1 expression and activity in cellular processes.
Additionally, modulators like JNK Inhibitor and Genipin influence ephrin-B1 by targeting specific signaling pathways. JNK Inhibitor activates ephrin-B1 by suppressing the JNK signaling pathway, relieving c-Jun-mediated inhibition. Genipin, on the other hand, activates ephrin-B1 by inhibiting RhoA activity, disrupting RhoA-dependent actin cytoskeleton rearrangements. The indirect activators, such as A769662 and PD 169316, target AMPK and p38 MAPK pathways, respectively, influencing ephrin-B1 expression and function in cellular processes. Similarly, Y-27632 activates ephrin-B1 by inhibiting ROCK, leading to decreased RhoA activity and enhanced ephrin-B1-dependent processes like axon guidance. In conclusion, ephrin-B1 activators showcase the intricate interplay between chemical modulators and the complex signaling pathways involved in regulating ephrin-B1 activity. Whether through direct inhibition of acetylation, relief from Notch-mediated repression, or modulation of specific signaling pathways, these chemicals contribute to our understanding of ephrin-B1 activation and its implications in various cellular processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Anacardic Acid activates ephrin-B1 by inhibiting the acetyltransferase activity of p300. It prevents p300-mediated acetylation of ephrin-B1, promoting its interaction with Eph receptors and enhancing downstream signaling for cell repulsion and adhesion. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
DAPT indirectly activates ephrin-B1 by inhibiting the Notch signaling pathway. As a γ-secretase inhibitor, DAPT hinders Notch cleavage, leading to decreased expression of Hes family proteins. This relief from Notch-mediated repression enhances ephrin-B1 expression and activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK Inhibitor activates ephrin-B1 by suppressing the JNK signaling pathway. Inhibition of JNK prevents c-Jun phosphorylation, relieving c-Jun-mediated inhibition of ephrin-B1. This allows for enhanced ephrin-B1-mediated cellular processes, such as axon guidance and migration. | ||||||
Genipin | 6902-77-8 | sc-203057 sc-203057A | 25 mg 100 mg | $82.00 $246.00 | 6 | |
Genipin activates ephrin-B1 by inhibiting RhoA activity. It forms cross-links with lysine residues, disrupting RhoA-dependent actin cytoskeleton rearrangements. The inhibition of RhoA enhances ephrin-B1-mediated signaling, facilitating cell repulsion and axon guidance. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A769662 activates ephrin-B1 indirectly by inhibiting the AMPK pathway. As an AMPK activator, A769662 modulates AMPK signaling, potentially influencing ephrin-B1 expression and function in cellular processes such as cell adhesion and axon guidance. | ||||||
PD 169316 | 152121-53-4 | sc-204168 sc-204168A sc-204168B sc-204168C | 1 mg 5 mg 10 mg 25 mg | $88.00 $156.00 $281.00 $461.00 | 3 | |
PD 169316 activates ephrin-B1 by inhibiting the p38 MAPK pathway. Inhibition of p38 MAPK prevents downstream signaling that negatively regulates ephrin-B1. This allows for increased ephrin-B1 expression and enhanced cellular processes such as axon guidance and repulsion. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 activates ephrin-B1 by inhibiting ROCK (Rho-associated protein kinase). Inhibition of ROCK leads to decreased RhoA activity, relieving RhoA-mediated inhibition of ephrin-B1. This enhances ephrin-B1-dependent processes like axon guidance and cell repulsion. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
FK506 activates ephrin-B1 indirectly by inhibiting the calcineurin-NFAT pathway. As a calcineurin inhibitor, FK506 prevents NFAT dephosphorylation and translocation, influencing ephrin-B1 expression and contributing to cellular processes such as axon guidance and repulsion. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 activates ephrin-B1 by inhibiting the MEK-ERK pathway. Inhibition of MEK prevents ERK phosphorylation, relieving ERK-mediated inhibition of ephrin-B1. This leads to enhanced ephrin-B1 expression and function in cellular processes such as axon guidance and cell repulsion. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin activates ephrin-B1 indirectly by inhibiting the PI3K-Akt pathway. As a PI3K inhibitor, Wortmannin prevents Akt activation, potentially influencing ephrin-B1 expression and cellular processes such as axon guidance and cell repulsion. | ||||||